The global urokinase API market has maintained steady growth momentum

The long-term stable clinical demand for thrombolytic drugs has driven sustained development of the global urokinase API market. As a urogenic bioactive substance, the stability and traceability of its raw material supply have become critical focal points of concern within the industry.